Velarde, Baby Boy .
HRN: 25-38-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
CEFOTAXIME 500MG (VIAL)
07/10/2024
07/17/2024
IVTT
170
Q12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes